 |
Dilaforette, AGU in deal for sickle cell clinical trialDilaforette, a Karolinska Development portfolio company focused on innovative treatments for patients with sickle-cell disease, and Bahrain-based Arabian Gulf University (AGU) have signed a clinical collaboration agreement for the Phase 2 proo More… |
Tuesday 5 November 2024
